Does CROVALIMAB-AKKZ Cause Type iii immune complex mediated reaction? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Type iii immune complex mediated reaction have been filed in association with CROVALIMAB-AKKZ. This represents 26.3% of all adverse event reports for CROVALIMAB-AKKZ.
10
Reports of Type iii immune complex mediated reaction with CROVALIMAB-AKKZ
26.3%
of all CROVALIMAB-AKKZ reports
1
Deaths
9
Hospitalizations
How Dangerous Is Type iii immune complex mediated reaction From CROVALIMAB-AKKZ?
Of the 10 reports, 1 (10.0%) resulted in death, 9 (90.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is Type iii immune complex mediated reaction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CROVALIMAB-AKKZ. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does CROVALIMAB-AKKZ Cause?
What Other Drugs Cause Type iii immune complex mediated reaction?
RITUXIMAB (25)
VANCOMYCIN (24)
HUMAN IMMUNOGLOBULIN G (23)
OXALIPLATIN (23)
METHOTREXATE (19)
MYCOPHENOLATE MOFETIL (18)
TACROLIMUS (18)
CYCLOPHOSPHAMIDE (17)
BORTEZOMIB (16)
CYCLOSPORINE (16)